CD80 Rabbit mAb
B7; BB1; B7-1; B7.1; LAB7; CD28LG; CD28LG1
Anti-mouse NK1.1 Antibody (Clone: PK136) | PA007525.m2a
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Rat IgG2a Isotype Control Antibody(Clone: 12B9) | PA007143
Recombinant rat IgG2a kappa isotype control good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. Mouse variable regions and rat IgG2a kappa constant regions.
Anti-Human HLA-DR Antibody, clone L243 | PA007453
Recombinant Mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Anti-mouse CD28 Monoclonal Antibody (Clone: 37.51) | PA007475.m1
Recombinant Mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Anti-human CD4 Antibody (Clone: SK3 / Anti-Leu 3a) | PA007386.m1
Recombinant mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Anti-mouse PD-1 Monoclonal Antibody (Clone 29F.1A12.1) | PA007163.r2a
Anti-mouse PD-1 Monoclonal Antibody (Clone 29F.1A12.1),Rat IgG2a Kappa, In Vivo Grade Recombinant. Anti-mouse PD1 monoclonal antibodies, which share the same variable region sequences with the rat anti-mouse PD-1 / CD279 monoclonal antibody (clone: 29F.1A12), are...
Anti-mouse CD40 Antibody (FGK4.5) | PA007274.m2a
Recombinant rat IgG2a isotype controls and Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Anti-mouse CTLA-4 Antibody (Clone: 9D9, CD152) | PA007380.m2aLA
Recombinant mouse IgG2b isotype control, Recombinant mouse IgG2c LALAPG isotype control, and Recombinant mouse IgG2a LALAPG isotype control are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.